ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.62
0.10%
US Tech 100
21,150.80
-0.73%
S&P 500
6,091.52
-0.44%
US Dollar vs CAD
1.43435
-0.25%
Bitcoin
105,098.56
1.09%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. BriaCell Therapeutics Corporation (BCTXW)

  7. BriaCell Therapeutics Corporation (BCTXW) News

BCTXW

BriaCell Therapeutics (BCTXW)

BriaCell Therapeutics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCTXW
DateTimeSourceHeadlineSymbolCompany
12/17/20243:05PMGlobeNewswire Inc.BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting ProceduresNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/17/20243:05PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/17/20243:05PMGlobeNewswire Inc.BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting ProceduresNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/16/20243:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCTXWBriaCell Therapeutics Corporation
12/16/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/13/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/13/20243:05PMGlobeNewswire Inc.BriaCell Therapeutics Announces Closing of $5.5 Million Public OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/13/20246:50AMGlobeNewswire Inc.BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/12/20244:27PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCTXWBriaCell Therapeutics Corporation
12/12/20245:06AMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BCTXWBriaCell Therapeutics Corporation
12/11/202410:54PMGlobeNewswire Inc.BriaCell Therapeutics Announces Pricing of $5.5 Million Public OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/11/20244:21PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCTXWBriaCell Therapeutics Corporation
12/11/20243:05PMGlobeNewswire Inc.BriaCell Therapeutics Announces Proposed Public OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/11/20246:50AMGlobeNewswire Inc.BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®NASDAQ:BCTXWBriaCell Therapeutics Corporation
12/10/20245:06AMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BCTXWBriaCell Therapeutics Corporation
12/05/20246:45AMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BCTXWBriaCell Therapeutics Corporation
12/02/20246:50AMGlobeNewswire Inc.BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
11/26/20246:50AMGlobeNewswire Inc.BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
11/25/20243:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
11/25/20246:50AMGlobeNewswire Inc.BriaCell Provides Update to its Board of DirectorsNASDAQ:BCTXWBriaCell Therapeutics Corporation
11/21/20246:50AMGlobeNewswire Inc.BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer StudyNASDAQ:BCTXWBriaCell Therapeutics Corporation
11/14/202411:17AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BCTXWBriaCell Therapeutics Corporation
11/08/20246:50AMGlobeNewswire Inc.BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC ConferenceNASDAQ:BCTXWBriaCell Therapeutics Corporation
11/04/20246:50AMGlobeNewswire Inc.BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13NASDAQ:BCTXWBriaCell Therapeutics Corporation
11/01/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
10/22/20246:50AMGlobeNewswire Inc.BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival DataNASDAQ:BCTXWBriaCell Therapeutics Corporation
10/15/20246:50AMGlobeNewswire Inc.BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal StudyNASDAQ:BCTXWBriaCell Therapeutics Corporation
10/02/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
10/02/20243:05PMGlobeNewswire Inc.BriaCell Therapeutics Announces Closing of $5 Million OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
10/02/20249:12AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCTXWBriaCell Therapeutics Corporation
 Showing the most relevant articles for your search:NASDAQ:BCTXW

Your Recent History

NASDAQ
RNAZ
TransCode Therapeutics
USOTC
CRTG
Coretec (CE)
NASDAQ
TNXP
Tonix Pharmaceuticals
NASDAQ
AMRN
Amarin
USOTC
TGLO
TheGlobe com (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
AZRH
Azure (PK)
NASDAQ
NVDA
NVIDIA
NYSE
AMC
AMC Entertainment
USOTC
RITE
MineralRite (PK)
NASDAQ
NB
NioCorp Developments
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
LWLG
Lightwave Logic
USOTC
CGAC
Code Green Apparel (PK)
USOTC
ASII
Accredited Solutions (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads